Elian, Saira .

HRN: 11-14-10  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/05/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
03/05/2023
03/12/2023
IV
500mg
Q 8hrs
S/P Cesarean Section
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: